COPE

Welcome to the Brand page for “COPE”, which is offered here for In the statement, column 1, line 2, kurfuersten-anlage 21 should be deleted, and kurfuersten-anlage 21 should be inserted. in the statement, column 1, line 25, 10/15/2015 should be deleted, and 02/10/2015 should be inserted.;administration of employee benefit programs which provide payment for genomic and molecular analysis and research to support treatment decisions in the treatment of cancer;consulting services, business consulting services in the nature of advising employers regarding health care benefits for employees;providing online databases featuring medical and diagnostic information relating to prophylactic and therapeutic properties of pharmaceuticals and genomic information relating to medical diagnosis and treatment medical consulting services in the field of cancer diagnosis and cancer therapy; medical consulting services, treatment decision support services in the field of use of genetic, clinical and molecular data relating to efficacy of drugs; medical consulting services in connection with treatment support programs offered by employers as an employee benefit; cancer genomic and molecular medical testing services; health care services, providing a database in the field of cancer-associated genetic and treatment information and featuring inputting and collection of data and information all for treatment and diagnostic purposes;.

Its status is currently believed to be active. Its class is unavailable. “COPE” is believed to be currently owned by “MOLECULAR HEALTH GMBH”.